CNNE Stock Analysis: Cannae Holdings | NYSE
Restaurants | NYSE, USA | Market Cap: 727m USD | 12M Return: 14.1% | US13765N1072 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 8.26M
Qual. Beats: 0
Rev. Trend: -95.2%
Qual. Beats: -1
Warnings
No concerns identified
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Cannae Holdings, Inc. (NYSE: CNNE) is a principal investment firm founded in 2014 and headquartered in Las Vegas, Nevada. The company invests across multiple sectors, with a focus on restaurants, technology-enabled healthcare services, and financial services, taking both minority and majority stakes in its portfolio companies. Listed on the NYSE in November 2017, Cannae operates within the financials sector as a multi-sector holding company.
As a multi-sector holding entity, Cannaes business model centers on actively managing a diversified portfolio of equity investments rather than generating revenue from a single operating business. This structure allows the firm to allocate capital across varied industries, balancing risk and pursuing returns through both controlling and non-controlling positions.
- Restaurant portfolio revenue pressured by consumer spending slowdown
- Healthcare technology investments drive segment growth and margins
- SPAC exposure and investment portfolio mark-to-market swings
| Net Income: -107.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 4.97 > 1.0 |
| NWC/Revenue: 20.25% < 20% (prev 31.26%; Δ -11.01% < -1%) |
| CFO/TA 0.02 > 3% & CFO 19.0m > Net Income -107.8m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.93 > 1.5 & < 3 |
| Outstanding Shares: last quarter (42.3m) vs 12m ago -22.67% < -2% |
| Gross Margin: 12.79% > 18% (prev -2.91%; Δ 15.70% > 0.5%) |
| Asset Turnover: 28.15% > 50% (prev 28.41%; Δ -0.26% > 0%) |
| Interest Coverage Ratio: -20.64 > 6 (EBIT TTM -121.8m / Interest Expense TTM 5.90m) |
| A: 0.07 (Total Current Assets 155.6m - Total Current Liabilities 80.7m) / Total Assets 1.11b |
| B: -0.02 (Retained Earnings -22.4m / Total Assets 1.11b) |
| C: -0.09 (EBIT TTM -121.8m / Avg Total Assets 1.31b) |
| D: 3.84 (Book Value of Equity 882.9m / Total Liabilities 229.9m) |
| Altman-Z'' = 3.79 = AA |
As of November 14, 2026, the stock is trading at USD 17.29 with a total of 518,179 shares traded. Over the past week, the price has changed by -2.26%, over one month by +9.99%, over three months by +12.21% and over the past year by +14.12%.
Current recommended Stop Loss: 15.60 (which is 9.8% or 2.8 ATR below the current price).
Cannae Holdings has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy CNNE.
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 17.3 | -0.2% |
P/E Forward = 8.9686
P/S = 1.7814
P/B = 0.835
Revenue TTM = 369.8m USD
EBIT TTM = -121.8m USD
EBITDA TTM = -101.9m USD
Long Term Debt = 64.6m USD (from longTermDebt, last quarter)
Short Term Debt = 12.3m USD (from shortTermDebt, last quarter)
Debt = 235.0m USD (from shortLongTermDebtTotal, last quarter) + Leases 84.7m
Net Debt = 123.3m USD (calculated: Debt 235.0m - CCE 111.7m)
Enterprise Value = 850.5m USD (727.2m + Debt 235.0m - CCE 111.7m)
Interest Coverage Ratio = -20.64 (Ebit TTM -121.8m / Interest Expense TTM 5.90m)
EV/FCF = 56.70x (Enterprise Value 850.5m / FCF TTM 15.0m)
FCF Yield = 1.76% (FCF TTM 15.0m / Enterprise Value 850.5m)
FCF Margin = 4.06% (FCF TTM 15.0m / Revenue TTM 369.8m)
Net Margin = -29.15% (Net Income TTM -107.8m / Revenue TTM 369.8m)
Gross Margin = 12.79% ((Revenue TTM 369.8m - Cost of Revenue TTM 322.5m) / Revenue TTM)
Gross Margin QoQ = 11.60% (prev 16.54%)
Tobins Q-Ratio = 0.76 (Enterprise Value 850.5m / Total Assets 1.11b)
Interest Expense / Debt = 2.51% (Interest Expense 5.90m / Debt 235.0m)
Taxrate = 34.88% (1.50m / 4.30m)
NOPAT = -79.3m (EBIT -121.8m * (1 - 34.88%)) [loss with tax shield]
Current Ratio = 1.93 (Total Current Assets 155.6m / Total Current Liabilities 80.7m)
Debt / Equity = 0.27 (Debt 235.0m / totalStockholderEquity, last quarter 882.9m)
Debt / EBITDA = -1.21 (negative EBITDA) (Net Debt 123.3m / EBITDA -101.9m)
Debt / FCF = 8.22 (Net Debt 123.3m / FCF TTM 15.0m)
Total Stockholder Equity = 955.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -8.21% (Net Income -107.8m / Total Assets 1.11b)
RoE = -11.28% (Net Income TTM -107.8m / Total Stockholder Equity 955.8m)
RoCE = -11.94% (EBIT -121.8m / Capital Employed (Equity 955.8m + L.T.Debt 64.6m))
RoIC = -7.73% (negative operating profit) (NOPAT -79.3m / Invested Capital 1.03b)
WACC = 6.64% (E(727.2m)/V(962.2m) * Re(8.26%) + D(235.0m)/V(962.2m) * Rd(2.51%) * (1-Tc(0.35)))
Discount Rate = 8.26% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -94.21 | Cagr: -15.75%
[DCF] Terminal Value 75.44% ; FCFF base≈15.0m ; Y1≈15.1m ; Y5≈16.0m
[DCF] Fair Price = 2.88 (EV 248.2m - Net Debt 123.3m = Equity 124.9m / Shares 43.4m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.04 | # QB: 0
Revenue Correlation: -95.19 | Revenue CAGR: -11.58% | SUE: -4.0 | # QB: -1
EPS current Quarter (2027-03-31): EPS=-0.38 | Chg30d=-40.74% | Revisions=+25% | Analysts=2
EPS current Year (2026-12-31): EPS=-0.45 | Chg30d=-3.45% | Revisions=-25% | GrowthEPS=+93.9% | GrowthRev=-8.2%
EPS next Year (2027-12-31): EPS=-1.49 | Chg30d=-4.95% | Revisions=-25% | GrowthEPS=-230.0% | GrowthRev=+0.9%
[Analyst] Revisions Ratio: -17% (up=1, down=2)